trehalose has been researched along with Fatty Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Chi, M; Crowley, JR; Davidson, NO; DeBosch, BJ; Finck, BN; Heitmeier, MR; Higgins, CB; Hruz, PW; Kraft, TE; Mayer, AL; Moley, KH; Newberry, EP; Yarasheski, KE | 1 |
1 other study(ies) available for trehalose and Fatty Liver
| Article | Year |
|---|---|
Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Fatty Liver; Glucose Transport Proteins, Facilitative; HEK293 Cells; Hep G2 Cells; Humans; Mice; Mice, Knockout; Trehalose | 2016 |